STC:DBD's ROE % is ranked better than 81.84% of 936
companies
in the Drug Manufacturers industry
Industry Median: 5.865
vs STC:DBD: 16.80
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Binh Dinh Pharmaceutical And Medical Equipment JSC ROE % Related Terms
Binh Dinh Pharmaceutical And Medical Equipment JSC ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC ROE % Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binh Dinh Pharmaceutical And Medical Equipment JSC ROE % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a ROE % of 18.08% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. This is near median its historical median of 17.78. Over the past decade, Binh Dinh Pharmaceutical And Medical Equipment JSC's ROE % has ranged from 15.60 to 19.52. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #170 out of 936 companies in the Drug Manufacturers industry, placing it in the top 18.2%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's ROE % too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current ROE % of 18.08% is near median its 10-year median of 17.78. Over the past 10 years, this metric has ranged from a low of 15.60 to a high of 19.52. The Drug Manufacturers industry median ROE % is 5.87. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 18.08% is 208.3% above this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #170 out of 936 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's ROE % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #170 out of 936 companies for ROE %. This places Binh Dinh Pharmaceutical And Medical Equipment JSC in the top 18% of its industry — outperforming the majority of peers. The industry median ROE % is 5.87. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 18.08% is 208.3% above this benchmark. Historically, Binh Dinh Pharmaceutical And Medical Equipment JSC's own ROE % has ranged from 15.60 to 19.52 over the past decade. While the company's 10-year median is 17.78 vs. the industry median of 5.87, Binh Dinh Pharmaceutical And Medical Equipment JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 5.87, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current ROE % of 18.08% is 208.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median ROE % is 5.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current ROE % is 18.08%, which is near median its own 10-year median of 17.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,212.47, compared to a current price of ₫53,200.00 — trading 1.9% above its estimated fair value. The current ROE % is 18.08%, which is near median its 10-year median of 17.78 and 208.3% above the Drug Manufacturers industry median of 5.87. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current ROE % is 18.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be overvalued.
The current stock price of ₫53,200.00 is trading 1.9% above its estimated GF Value™ of ₫52,212.47.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
ROE %: 18.08% (near median its 10-year median of 17.78)
GF Value™: ₫52,212.47 vs. price of ₫53,200.00 (1.9% above fair value)
Industry Position: 208.3% above the Drug Manufacturers median (#170 of 936)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
